Ichor Biologics seeks $80-100 million private equity funding

Hyderabad-based biopharmaceutical firm Ichor Biologics is looking to raise $80-100 million by selling a significant minority stake, with Alvarez & Marsal appointed to manage the process. The company, which specializes in plasma therapy products, reported $14.7 million in FY25 revenue, down from $17 million, as Ebitda halved to $2 million.